A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Insulin detemir
Dexibuprofen
The risk or severity of gastrointestinal bleeding can be increased when Levomilnacipran is combined with Dexibuprofen.
Insulin detemir
Aceclofenac
The risk or severity of gastrointestinal bleeding can be increased when Levomilnacipran is combined with Aceclofenac.
Insulin detemir
Lornoxicam
The risk or severity of gastrointestinal bleeding can be increased when Levomilnacipran is combined with Lornoxicam.
Insulin detemir
Tiaprofenic acid
The risk or severity of gastrointestinal bleeding can be increased when Levomilnacipran is combined with Tiaprofenic acid.
Insulin detemir
Antrafenine
The risk or severity of gastrointestinal bleeding can be increased when Levomilnacipran is combined with Antrafenine.
Insulin detemir
Choline magnesium trisalicylate
The risk or severity of gastrointestinal bleeding can be increased when Levomilnacipran is combined with Choline magnesium trisalicylate.
Insulin detemir
Salsalate
The risk or severity of gastrointestinal bleeding can be increased when Levomilnacipran is combined with Salsalate.
Insulin detemir
Magnesium salicylate
The risk or severity of gastrointestinal bleeding can be increased when Levomilnacipran is combined with Magnesium salicylate.
Insulin detemir
Flurbiprofen axetil
The risk or severity of gastrointestinal bleeding can be increased when Levomilnacipran is combined with Flurbiprofen axetil.
Insulin detemir
Ebselen
The risk or severity of gastrointestinal bleeding can be increased when Levomilnacipran is combined with Ebselen.
Insulin detemir
Polmacoxib
The risk or severity of gastrointestinal bleeding can be increased when Levomilnacipran is combined with Polmacoxib.
Insulin detemir
Taxifolin
The risk or severity of gastrointestinal bleeding can be increased when Levomilnacipran is combined with Taxifolin.
Insulin detemir
Methylene blue
Levomilnacipran may increase the serotonergic activities of Methylene blue.
Insulin detemir
Chloride ion
Levomilnacipran may increase the tachycardic activities of Chloride ion.
Insulin detemir
4-Bromo-2,5-dimethoxyphenethylamine
Levomilnacipran may increase the tachycardic activities of 4-Bromo-2,5-dimethoxyphenethylamine.
Insulin detemir
Racephedrine
Levomilnacipran may increase the tachycardic activities of Racephedrine.
Insulin detemir
Xamoterol
Levomilnacipran may increase the tachycardic activities of Xamoterol.
Insulin detemir
Prenalterol
Levomilnacipran may increase the tachycardic activities of Prenalterol.
Insulin detemir
Tretoquinol
Levomilnacipran may increase the tachycardic activities of Tretoquinol.
Insulin detemir
Rimiterol
Levomilnacipran may increase the tachycardic activities of Rimiterol.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3